Alerts will be sent to your verified email
Verify Email
KILITCH
|
Kilitch Drugs(India)
|
Jenburkt Pharma
|
Prevest Denpro
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.31 % | 18.49 % | 19.0 % |
|
5yr average Equity Multiplier
|
1.48 | 1.17 | 1.07 |
|
5yr Average Asset Turnover Ratio
|
0.56 | 0.88 | 0.6 |
|
5yr Avg Net Profit Margin
|
8.44 % | 18.1 % | 29.64 % |
|
Price to Book
|
1.72 | 2.56 | 4.3 |
|
P/E
|
17.57 | 14.42 | 25.1 |
|
5yr Avg Cash Conversion Cycle
|
14.76 Days | -32.02 Days | 42.6 Days |
|
Inventory Days
|
14.42 Days | 24.72 Days | 36.0 Days |
|
Days Receivable
|
136.16 Days | 48.38 Days | 44.41 Days |
|
Days Payable
|
212.73 Days | 82.6 Days | 39.32 Days |
|
5yr Average Interest Coverage Ratio
|
6.02 | 87.2 | 99.71 |
|
5yr Avg ROCE
|
11.26 % | 24.44 % | 25.39 % |
|
5yr Avg Operating Profit Margin
|
12.28 % | 22.46 % | 36.91 % |
|
5 yr average Debt to Equity
|
0.17 | 0.02 | 0.0 |
|
5yr CAGR Net Profit
|
48.72 % | 14.21 % | 2.94 % |
|
5yr Average Return on Assets
|
4.99 % | 15.8 % | 17.71 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.77 % | 46.65 % | 73.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.48 % | 0.68 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kilitch Drugs(India)
|
Jenburkt Pharma
|
Prevest Denpro
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|